Abdulmelik Aytatli
Overview
Explore the profile of Abdulmelik Aytatli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caglar H, Aytatli A, Barlak N, Karatas E, Tatar A, Sahin A, et al.
Head Neck
. 2024 May;
46(9):2178-2196.
PMID: 38752376
Background: This study aimed to identify a candidate gene associated with paclitaxel (PTX) resistance and to evaluate functionally its biological role in the PTX-resistant head and neck squamous cell carcinoma...
2.
Ertugrul B, Aytatli A, Karatas O, Saracoglu N
RSC Med Chem
. 2023 Jul;
14(7):1362-1376.
PMID: 37484572
Modulation of existing drugs is an attractive strategy to achieve improved activity in cancer therapy by lowering their effective dose. Preparation of relatives has been suggested and explored to improve...
3.
Aytatli A, Barlak N, Sanli F, Caglar H, Gundogdu B, Tatar A, et al.
Cell Oncol (Dordr)
. 2021 Nov;
45(1):41-56.
PMID: 34837170
Purpose: Development of chemoresistance is one of the major obstacles to the treatment of head and neck squamous cell carcinoma (HNSCC). The PI3K/Akt pathway, involved in drug resistance, has been...
4.
Barlak N, Capik O, Kilic A, Sanli F, Aytatli A, Yazici A, et al.
Cell Biol Int
. 2021 Jan;
45(5):1082-1090.
PMID: 33501702
Prostate cancer (PCa) is one of the most prevalent cancer types among males. Differential expression of microRNAs is associated with various cancers including PCa. Although mature microRNAs are preferentially located...
5.
Kilic A, Barlak N, Sanli F, Aytatli A, Capik O, Karatas O
Laryngoscope
. 2019 Dec;
130(12):2818-2824.
PMID: 31886905
Objectives: In this study, we aimed at investigating the expressions of miR-145 and its well-characterized direct targets on carboplatin treatment. Study Design: Laboratory study. Methods: The effect of carboplatin and...
6.
Barlak N, Capik O, Sanli F, Kilic A, Aytatli A, Yazici A, et al.
Cell Biol Int
. 2019 Sep;
44(1):242-252.
PMID: 31475765
Prostate cancer (PCa) is one of the most common types of cancer in men. In several recent studies, chromosomal deletions in the q arm of chromosome 2, where ING5 resides...